Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15079019 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
IVIG Treatment for Refractory Immune-Related Adult Epilepsy
Conditions: Epilepsy, Cryptogenic;   Epilepsy, Partial;   Seizure Disorder;   Autoimmune Diseases, Nervous System;   Limbic Encephalitis
Intervention: Drug: IVIG

Indicates status has not been verified in more than two years